Healthcare professionals often use subcutaneous injections for medications, such as insulin, which need to be absorbed into the bloodstream slowly and steadily. Subcutaneous injections are usually ...

Steqeyma is now supplied as a 45mg/0.5mL solution in a single-dose vial for subcutaneous injection, allowing for weight-based dosing for pediatric patients under 60kg.

Education before subcutaneous daratumumab administration can both reassure patients and reduce the occurrence of adverse ...

MISSISSAUGA, ON, June 11, 2025 /CNW/ - Hoffmann-La Roche Limited (Roche Canada) is pleased to announce that Health Canada has authorized PiaSky® (crovalimab for injection) as the first monthly (every ...

Celltrion, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a new presentation of STEQEYMA® (ustekinumab-stba), a biosimilar to STELARA® (ustekinumab), in a ...

Celltrion, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a new presentation of STEQEYMA® (ustekinumab-stba), a biosimilar to STELARA® (ustekinumab), in a ...

This fat is called visceral fat. A subcutaneous injection is an effective method of injecting some medications. People can administer these injections into sites on the outer surface of the upper ...

every 3 days); murine EX104 (subcutaneous injection, 0.1 mL/animal, every 3 days); minoxidil (topical application, 0.2 mL/animal, daily). As illustrated in the figure, at day 15 post-treatment ...

Panelists discuss how subcutaneous (SubQ) drug formulations offer practical value by significantly reducing treatment times, easing staffing pressures, and enhancing efficiency in oncology practices, ...

Bristol Myers Squibb's Opdivo has been approved in a subcutaneous injection formulation by the FDA, making treatment easier for patients and potentially adding years to the product's patent life.

IRAKLIA, the first phase 3 multiple myeloma study to use an on-body injector, finds the same efficacy and pharmacokinetics in ...